1999
DOI: 10.1001/archinte.159.21.2576
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Macrolides as Part of Initial Empiric Therapy on Length of Stay in Patients Hospitalized With Community-Acquired Pneumonia

Abstract: Use of macrolides as part of an initial therapeutic regimen appears to be associated with shorter LOS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
67
2
6

Year Published

2000
2000
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 150 publications
(78 citation statements)
references
References 32 publications
3
67
2
6
Order By: Relevance
“…Several retrospective studies have suggested that the use of a macrolides/b-lactams combination, as part of the initial antimicrobial treatment, for patients with CAP, requiring hospital admission, may shorten the hospital stay [6,7] and reduce the mortality rate in comparison with those treated with monotherapy [8][9][10], even when S. pneumoniae is finally identified as the causative organism [11][12][13]. However, many aspects of the apparently beneficial effects of combined therapy remain unclear and/or controversial.…”
mentioning
confidence: 99%
“…Several retrospective studies have suggested that the use of a macrolides/b-lactams combination, as part of the initial antimicrobial treatment, for patients with CAP, requiring hospital admission, may shorten the hospital stay [6,7] and reduce the mortality rate in comparison with those treated with monotherapy [8][9][10], even when S. pneumoniae is finally identified as the causative organism [11][12][13]. However, many aspects of the apparently beneficial effects of combined therapy remain unclear and/or controversial.…”
mentioning
confidence: 99%
“…This study also revealed a significant association between age and antibiotic therapy prescribed for levofloxacin, azithromycin, and meropenem among pilgrims. The old medical guideline has revealed that the outcome for elderly patients (age over 65 years with comorbidities) with CAP may improve when a macrolide agent (azithromycin, erythromycin, or clarithromycin) is combined with a second-or third-generation cephalosporin [44,45]. High frequency of atypical pathogens causing mixed pneumonia might be categorised as a key success of the macrolide agent [46].…”
Section: Discussionmentioning
confidence: 99%
“…In a study including more than 3,200 patients, Yealy et al found that 71.9% of hospitalizations were in Table 2 immunomodulatory effect of macrolides than to the antimicrobial effect of those antibiotics. (23) Broad-spectrum antibiotic therapy, including the combined use of beta-lactam antibiotics and macrolides, aims at broadening the coverage of gram-negative bacteria, as well as of atypical or resistant pathogens. However, the incidence of such agents is higher in cases that are more severe, S. pneumoniae remaining the principal etiologic agent in CAP that is less severe (CURB-65 score, 0-1).…”
Section: Discussionmentioning
confidence: 99%